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Abstract
The purpose of this integrated review of the literature was to determine the relationship between
therapeutic hypothermia and cardiac arrhythmias. The reviewed literatures were English based
articles from year 2003-2013. Relevant information from the American Heart Association and
the International Liaison Committee on Resuscitation was used to further enhance research
results. The results of this literature review showed hypothermia treatment propensity to prolong
QT interval without precipitating life-threatening arrhythmias. Although arrhythmias can be
potentially increased under induced hypothermia, it has been shown that treatment is easier while
under hypothermic conditions. The reviewed research also shows that hypothermia treatment
should be expanded to include more circumstance besides ventricular cardiac arrest. It was
suggested that the reason for lack of use of hypothermia treatment under the suggested
conditions was due to the restricted circumstances in which it is suggested to be used. Other
recommendations include increased monitoring for cardiac rhythms during cardiac arrhythmias
and protocols for arrhythmia treatment.
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Introduction
Induced Hypothermia
Medically induced hypothermia, as it relates to cardiac arrest, is the cooling of the core
body temperature to 32-34̊ C (89.6-93.2̊ F) (Holden & Makic, 2006). There are three recognized
stages of hypothermia: mild, moderate and severe. Mild hypothermia is from 33-35̊ C (91.4-95̊
F), moderate from 28-32̊ C (82.4-89.6̊ F) and severe < 28̊ C (82.4̊ F). The therapeutic range is
within the mild to moderate levels (Holden & Makic, 2006).
The use of hypothermia in cardiac arrest patients has been documented since the late
1950’s (Polderman, 2008). Although successful, it was subsequently abandoned due to uncertain
benefits and difficulties with its use. As providers have grown better able to manage therapeutic
hypothermia, it has emerged as an important therapy following cardiac arrest by increasing
survivability and offering neuroprotectition (Mooney et al., 2011).
Hypothermia treatment is not without adverse effects. Hypothermia treatment has been
shown to cause various cardiac arrhythmias including QT prolongations, and bradycardia due to
the decrease in oxygen demands in response to lower temperatures. There is also evidence that
therapeutic hypothermia increases the risk of infection and coagulopathy (Storm et al., 2011).
Hypothermia is thought to reduce tissue injury by reducing metabolic need, ATP
preservation, and has even shown a positive effect on myocardial contractility. By reducing
metabolism, mild hypothermia is believed to suppress injuries associated with reperfusion injury.
Some of these injuries include calcium shifts, free radical production, and apoptosis (Nolan et al.,
2003).
Hypothermia treatment has also been shown to reduce infarct size when administered
prior to return of spontaneous perfusion (Götberg, Olivecrona, Götberg, Koul, & Erlinge, 2010).
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Hypothermia treatment has also shown positive effects in neurological outcomes of cardiac arrest
patients. Hypothermia reduces cerebral metabolic demand by 6% for every 1̊C reduction in body
temperature.
Hypothermia treatment must be carefully implemented due to the potential for adverse
effects. Hypothermia is thought to decrease the depolarization of pacemaker cells thereby
extending the duration of action potentials. The most common electrocardiograpic changes were
the prolongation of the PR and QT intervals and the widening of the QRS complex.
Induced hypothermia has also shown to increase the presence of Osborn waves, which
have been associated with ventricular ectopy (Bell, 2010). The hypothermic cooling process has
been shown to correlate with a decrease in potassium levels, which is thought to potentiate the
arrhythmias; polymorphic ventricular tachycardia (PVT) shows the strongest association with
hypokalemia (Mirzoyev, McLeod, Bunch, Bell, & White, 2010).
Cardiac Arrhythmias
Hypothermia treatment has a strong association with cardiac arrhythmias. Ventricular
arrhythmias are a major cause of death in hospitalized patients post cardiac arrest (Mirzoyev et
al., 2010). QT prolongations themselves have been shown to induce malignant arrhythmias such
as ventricular tachycardia. However, elongations of QT intervals are easier to treat while under
hypothermic conditions (Storm et al., 2011).
In 2009, Tiainen et al. stated that hypothermia treatment did not have a clinically
significant impact on arrhythmias. They claimed that heart rate could be an indicator of a
favorable outcome. Hypothermic cardiac arrhythmias could also be caused by other life saving
measures such as medications. Hypothermic treatment can increase the effects of drugs and
further prolong QT intervals to potentially dangerous degrees.
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Problem
Therapeutic hypothermia has been linked to favorable outcomes for post cardiac arrest
victims. Medically induced hypothermia is also thought to offer protective mechanisms in
cardiogenic shock patients (Götberg et al., 2010). Close cardiac monitoring is needed due to the
potential for cardiac arrhythmias especially if the patient is treated with medications that can
further prolong QT intervals. Healthcare awareness of the potential for dangerous arrhythmias
affects treatment during and post induced hypothermia.
Hypothermic treatment has been endorsed by the International Liaison Committee on
Resuscitation; therefore, its use has become increasingly widespread. With the widespread use of
a potentially beneficial treatment, healthcare has the moral and ethical obligation to know and
prepare for potential adverse effects. Although there is moderate knowledge about the potential
for cardiac arrhythmias, there is no comprehensive action plan to treat these occurrences. It is not
only important to know that adverse effects can happen, but it is also important to have protocols
in place for such events.
With the increasing demand on the healthcare system due to the influx of newly insured
individuals, it has become even more important to eliminate potential problems before they
occur. Not only is it important for patients, but it is also the economically responsible thing to do.
With limited resources and a potential influx of patients, it is more important than ever to
streamline protocols using the newest and most efficient evidence based practices. Examining
the current literature on induced hypothermia and cardiac arrhythmias is instrumental in the
adoption of protocols within the health care facility.
As healthcare participants and patient advocates, nurses are responsible for providing
assessments vital to preventing malignant cardiac arrhythmias. It is imperative that nurses know

3

how to treat and prevent possible arrhythmias. A knowledgeable nursing staff is at the forefront
of safety and positive patient outcomes. Understanding what adverse effects are possible, and the
potentiating factors that can cause them, is crucial in limiting harmful outcomes. Because
medically induced hypothermia is such a new mode of therapy, there is, currently, a lack of
knowledge as it relates to complications, protocols, and treatment in this area. Current literature
endeavors to fill these voids but no standard protocols have been established.
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Purpose
The ambition of this integrated review is to provide a comprehensive analysis of the
research on therapeutic hypothermia and its correlation with cardiac arrhythmias. An
examination of the various levels of hypothermia and the adverse effects shown at each specific
level will be analyzed. This analysis will look for clinically significant findings. The literature
reviewed will provide insight to understanding various therapeutic hypothermia protocols. This
thesis will provide supplementary understanding of nursing related care for cardiac patients
given hypothermic treatment. The goal of this review is to positively impact nursing and patient
management by suggesting protocols that may be used in the care of patients undergoing
therapeutic hypothermia.
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Method
An examination of current research related to therapeutic hypothermia in cardiac patients
was conducted. Animal studies were included in the synthesis of research articles. An
interdisciplinary literature review search was completed using CINAHL, pubMED, and medline.
Inclusion conditions included peer reviewed, full text, and English language articles between the
years of 2003 and 2013. The search parameters were limited to those which included medically
induced hypothermia, cardiac patients, encouraging effects, and adverse effects.
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Background
Therapeutic hypothermia treatment has been highly praised for its neuroprotective
abilities and overall survival for post cardiac arrest patients. Hypothermia has also been
associated with increasing arrhythomogenic propensity of the heart. In accidental hypothermia
cases, marked increases in arrhythmias have been noted (Tiainen et al., 2009). Clinically
significant arrhythmias in experimental studies have not been conclusive.
Irreversible brain and heart damage continue to be common outcomes for a post cardiac
arrest patient. Therapeutic hypothermia has given patients the best chance of positive cardiac and
neurological outcomes. Induced hypothermia has been endorsed by the American Heart
Association and the International Liaison Committee on Resuscitation, yet it is absent from many
advance cardiac life support protocols in hospitals. This is due to many reasons including the
lack of familiarity with the treatment itself, lack of advance protocols, and the limited availability
of newer less cumbersome cooling devices (Erb, Hravnak, & Rittenberger, 2012).
Often there is no identifiable cause of arrhythmias associated with hypothermia. For
instance, a cardiac arrest patient receiving hypothermia therapy, who also happens to be a trauma
victim, could have issues associated with head or chest trauma leading to arrhythmias. Chest
traumas specifically lead to contusions of the heart affecting its rhythmicity.
Traumas are common with cardiac arrest patients due to the engaging of activity prior to
cardiac arrest. Head traumas such as subarachnoid hemorrhages can lead to arrhythmias.
Catecholamines, given as medications after cardiac arrest, can cause heart rhythm disturbances
(Bell, 2010). After these factors have been explored, one must take into account the propensity of
hypothermia to cause cardiac arrhythmias.
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Not all arrhythmias associated with hypothermia are due to reentry. Excessive
prolongations of action potentials can lead to early depolarizations, polymorphic ventricular
tachycardia, or degenerative ventricular fibrillation (Trohman & Neiger, 2012).
For hypothermic treatment to be effective, cardiac arrest first needs to be recognized
quickly, and treatment must be initiated and maintained for 12-24 hours once the desired core
temperature has been reached (Tiainen et al, 2009).When initiating hypothermia treatment it is
imperative to understand how the treatment works.
It was originally thought that the positive outcomes attributed to therapeutic hypothermia
were associated with the lowering of temperature as fast and as low as possible, with patients
routinely undergoing severe or deep hypothermia. The benefits of hypothermia treatment were
thought to be achieved by decreasing brain metabolism and oxygen demand. Cooling and
rewarming temperatures and applications varied greatly until the 1960’s when the use of
intensive care units became more widely available (Polderman, 2009).
Early History
Hypothermia was considered to offer better outcomes than the standard of care during the
1950’s to early 1960’s. These positive outcomes were despite uncontrollable cooling methods,
variable results, and indeterminate cooling times. By the late 1960’s, hypothermia treatment was
all but done away with due to substantial problems with patient management. Hypothermia
treatment would not come on the radar again until the 1980’s after a series of successful animal
trials rekindled the interest in hypothermia treatment (Polderman, 2009).
It was postulated that the positive outcomes associated with hypothermia were associated
with less drastic changes in temperature. Protective mechanisms were more associated with mild
to moderate hypothermia. Patients had drastically fewer adverse reactions and the reactions that
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did occur were more manageable (Polderman, 2008). Subsequent studies focused on time,
duration, depth, and management of adverse effects.
Recent Advances
Mild therapeutic hypothermia use in the intensive care setting has increased drastically
but opportunity still exists for furthering use. Hypothermia use is no longer being restricted to
treating only ventricular tachycardia and ventricular fibrillation, but is also used to treat asystole
and pulseless electrical activity with success (Lebiedz, 2012). If hypothermia treatment use can
be expanded to non-ventricular fibrillation cardiac events, it may be seen as viable option for
healthcare providers.
The limited therapeutic options of therapeutic hypothermia are a reason for low levels of
adherence to current AHA protocols. Although therapeutic hypothermia has the potential for
increased utilization, there are clear contraindications. Some contraindications include preexisting severe coagulation disorders, relevant head trauma, cardiogenic shock, sepsis, high
doses of catecholamines, and significant arrhythmias (Lebiedz, 2012).
The International Liaison Committee on Resuscitation (2002) recommended hypothermia
treatment for patients that are unconscious with spontaneous return of circulation. These
individuals should be cooled to 32̊ C to 34̊ C for 12 to 24 hours when the initial rhythm was
ventricular fibrillation.
The committee also stated that cooling may be advantageous for other rhythms or inhospital cardiac arrest. The American Heart Association (2010) added to these guidelines with,
“active rewarming should be avoided in comatose patients who spontaneously develop a mild
degree of hypothermia (>32̊ C) after resuscitation from cardiac arrest during the first 48 hours
after return of spontaneous circulation” (p. 772).
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Summary
Originally, therapeutic hypothermia was used with mixed results due to inability to
manage adverse effects. There were also issues with the cooling process, with the use ice slabs,
or open windows during the winter (Polderman, 2008). Detection and control of arrhythmias
were also less reliable due to lack of intensive care units. The units at that time were not
equipped to manage cardiac arrest patients being treated with therapeutic hypothermia. Modern
intensive care units and anti-arrhythmic medication has increased the viability of therapeutic
hypothermia treatment for cardiac arrest patients.
The current literature is inconclusive on clinically significant arrhythmias arising from
induced hypothermia. The effects of hypothermia cannot be isolated from other lifesaving
measures. Although evidence of arrhythmias remains inconclusive, treatment is endorsed by the
American Heart Association and ILCOR to be used in cardiac arrest after return of spontaneous
circulation. The neurologic and cardiac protective abilities of hypothermia treatment offer
benefits that other treatments cannot.
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Results
Of the twelve articles included in this literature review, six are summarized below. They
are also summarized in Table 1. These studies include primary research, systemic, and
integrative reviews. Univariate analysis, multivariate and heart rate variables were used to
determine success based on the initial study. Duration and type of arrhythmia were assessed.
This was assessed against normothermic conditions. Any clinically significant differences were
noted.
Most of the studies included data on witnessed out of hospital cardiac arrest. Some
studies were retrospective studies with duration of days to weeks. Studies included male and
female cardiac arrest victims. No gender differences were found. Various outcome scales were
used.
Tiainen et al (2009) performed a randomized cardiac arrest trial to determine the effects
of hypothermia treatment on arrhythmias in post cardiac arrest patients. To be included patients
had to be admitted to the Helsinki University Hospital after resuscitation from an out of hospital
cardiac arrest. The cardiac arrest had to be witnessed. Presumed cardiac event had to be
ventricular fibrillation or nonperfusing ventricular tachycardia as the initial rhythm. The patient
had to be unconscious and 18-75 years of age.
All data were collected Utstein style with the recommended guidelines for uniform
reporting of data from out-of-hospial cardiac arrest. Seventy participants were included with no
significant differences noted to their baseline characteristics. Cardiac enyzmes were higher in the
hypothermia groups. Patients were placed on Holter monitors for which time frame recordings
were broken down from 0-24 hours, 24-48, and 14 days.
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Arrhythmias were noted as premature ventricular beats (PVB), couplets, ventricular
tachycardia, and supraventricular premature beats (SVPB). PVBs and couplets were increased in
the hypothermic groups while ventricular tachycardia and ventricular fibrillation did not vary
between groups. At 14 days post cardiac arrest, there were no significant differences between the
groups. The final outcomes were assessed using the Pittsburgh outcome scale which is a five
category scale based on cerebral performance CPC 1-2 indicating favorable outcome.
Hypothermia treated patients had a 69% favorable outcome compared to 47% of normothermic
treated patients.
Kelly and Nolan (2009) used a systematic search to analyze the effects of hypothermia on
the myocardium. Only patients who spoke English and who were older than 18 years of age were
used. Excluded were accidental hypothermia, cardiac surgery, traumatic brain injury and
fulminant liver failure. These selected studies were assessed and graded using the Scottish
Intercollegiate Guidelines Network (SIGN).
Kelly and Nolan (2009) suggested that myocardial function may be improved by mild
medically induced hypothermia. This could be due to improved myocardial blood flow,
improved microvascular integrity, and reduction in no-flow zones and myocardial necrosis.
There was an increase in various arrhythmias including atrial and ventricular arrhythmias and
prolonged asystole. These arrhythmias were particularly common at temperatures below 32̊ C.
Mild hypothermia, which is most closely associated with induced hypothermia treatment,
showed no clinically significant increase in arrhythmias. Rather, the study found that cooling
was associated with decreased arrhythmias. Positive deflections at the end of the QRS complex
called Osborn, or J-waves, were noted on ECG of patients undergoing hypothermia treatment.
These usually appear at temperatures of 30̊ C and below and are also noted to be clinically
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insignificant. These waves were attributed to extremely low temperatures in which they appeared
and disappeared during rewarming.
T-wave inversion due to prolongation of ventricular repolarization could be seen during
mild hypothermia. These were usually associated with myocardial ischemia or repolarization
issues of the myocardium.
Poldermann (2008) looked specifically at the mechanism of action that leads to the
physiological effects on the myocardium that produces arrhythmias. It was determined that
cooling has an effect on electrolytes. A combination of intracellular shift and tubular dysfunction
associated with hypothermia can lead to the excretion of electrolytes. These electrolytes
primarily associated with this were magnesium, potassium, and phosphate.
The depletion of these electrolytes put the patient at increased risk for arrhythmias.
Medically induced hypothermia also caused the prolongation of the duration of action potentials
and decreased the rate of spontaneous depolarization therefore making the heart susceptible to
arrhythmias, the most common being prolonged intervals between the PR and QT phases and the
widening of the QRS complex.
These arrhythmias are uncommon and rarely require further treatment. Overall, mild
hypothermia treatment was related to a decreased chance of arrhythmia and also related to a
more favorable outcome if defibrillation was needed due to the hypothermia stabilizing the cell
membrane. Deep hypothermia was related to unsuccessful defibrillation and unresponsiveness to
antiarrhythmic drugs.
Patients in deep hypothermia were most susceptible to atrial fibrillation. Cardioversion at
< 34̊ C was frequently unsuccessful leading atrial fibrillation to ventricular fibrillation. The
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researchers concluded that, although there is potential for arrhythmias, hypothermia treatment
should not be withheld.
Lebiedz et al. (2012) used an observational single-center study in order to analyze
electrocardiographic changes, arrhythmias and complication rate before, during and after mild
therapeutic hypothermia. One hundred and nine, comatose patients underwent mild therapeutic
hypothermia. Excluded from this study were those patients with severe coagulation disorders,
sepsis, or poor prognosis.
Most patients met the target temperature of 32-34̊ C within 6 hours. During this time, a
significant decrease in heart rate, and prolongation of PR and QT intervals were noted, but were
not thought to be clinically significant. Patients with QT prolongation had not been given
medication to lengthen QT intervals nor was it found to be associated with ventricular ectopy or
torsades de pointes. No specific gender differences were noted in lengthened QT intervals.
Two patients developed ventricular fibrillation during hypothermia and both had an acute
myocardial infarction which the researchers related to acute myocardial ischemia. There were no
second or third degree AV-blocks although five patients’ treatment ended due to symptomatic
sinus-bradycardia.
Storm et al (2011) conducted a 34 patient prospective study to evaluate the incidence of
malignant arrhythmias and the possible effects of hypothermia on QT intervals. They followed
the guidelines of the American Heart Association and the European Resuscitation Council.
Hypothermia treatment was begun directly after admission. Holter ECG monitor readings
were analyzed by two independent experienced observers. Arrhythmias were classified as (3-5)
beats, non-sustained beats (between 5 and 29 beats), or sustained ventricular tachycardia (greater
than 30 beats).
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Three patients experienced ventricular tachyacardia. None experienced torsades de
pointes. QT interval was significantly prolonged during hypothermia but decreased after
hypothermia to baseline levels. The arrhythmias did not require additional treatment. All patients
completed 48 hours of hypothermia treatment without any fatalities.
Mirzoyev et al. (2010) tested the theory that arrhythmogenesis, associated with
hypothermia, was due to hypokalemia. An observational retrospective analysis of potassium
variability with therapeutic hypothermia was performed along with a correlative analysis of QT
intervals and ventricular arrhythmias.
Enrolled were 94 sequential patients that were victims of out-of-hospital cardiac arrest.
Their serum potassium levels were monitored meticulously. This study included patients who
were victims of ventricular fibrillation and pulseless electrical activity who had return of
spontaneous circulation. Seven patients had their treatment discontinued due to advance
directives, severe hemodynamic or respiratory failure and family request of withdrawal of care.
Thermoregulation equipment was used to achieve and maintain a core body temperature
of 33̊ C for 24 hours. It was found that serum potassium concentrations dropped considerably
during hypothermia. This corresponded with a prolonged QT interval. Polymorphic ventricular
tachycardia (PVT) was recurrent in 9 patients, with further treatment of PVT being necessary.
Patients with PVT had a significantly lower potassium level than other patients in their
cohorts. QT was analyzed with telemetry recordings within the hour of PVT. When severe
hypokalemia was noted anti-arrhythmic and vasoactive drugs had no effects on PVT.
The pro-arrhythmic properties of hypothermia treatment have been well established. It is
thereby critical to understand the electrophysiological effects. Piktel et al (2011) tested the
hypothesis that stated, “hypothermia-enhanced transmural dispersion of repolarization (DOR) is

15

a mechanism of arrhthmogenesis in hypothermia” (p. 79). They also investigated the degree of
hypothermia, rate of temperature change, and cooling versus warming would have an effect on
hypothermia-induced arrhythmia substrates.
Higher heterogeneities of repolarization are correlated with increased reentrant excitation
and arrhythmogenesis. The slowing of conduction during introduction of hypothermia reduced
arrhythmia susceptibility because it reduces hypothermia-induced repolarization gradients.
Hypothermia was shown to increase action potential dispersion and conduction block and reentry
occurred where action potential dispersion was greatest. As rewarming occurred, conduction
velocity increased but dispersion of repolarization stayed the same increasing the risk of
arrhythmias. Interestingly, increases in cooling and rewarming rate did not have an effect on
dispersion or repolarization. This suggested that the depth of hypothermia and not the rate had
the greatest effect on arrhythmogenesis.
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Discussion
The studies explored provided significant insight into medically induced hypothermia and
its potential negative effects on cardiac arrhythmias. In addition to some potential adverse
reactions to medically induce hypothermia, it has been noted that medically induced hypothermia
has a positive effect on cardio and neuro outcomes for patients. It has also been shown that
medically induced hypothermia can be managed with success in the intensive care units. Based
on these findings it is suggested that induced hypothermia can be used with success in cardiac
arrest patients, with the appropriate health care management.
Heart Rate Variability
Medically induced hypothermia patients had greater heart rate variability then
normothermic patients. There were two possible explanations. It may be that heart rate
variability is inversely proportional to heart rate, and/or that heart rate variability is a response to
bradycardia induced by hypothermia.
Second, it may be that there are temperature induced changes in automaticity that
increase heart rate variability. The low temperature may hamper atrial synchronization. The heart
rate variability induced by hypothermia can have a positive effect on the heart. The cold protects
the heart against ischemic events by increasing the perfusion to the cardiac muscle.
Heart rate variability is considered a measure of autonomic influence; therefore
disturbances in variability result in increased adverse effects (Mirzoyev et al., 2010). These
adverse effects include the increase in ventricular tachycardias. Hypothermia may, in fact,
preserve autonomic regulation of the heart. This could be the mechanism by which heart rate
variability is preserved. Heart rate variability was associated with more favorable outcomes in
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medically induced hypothermia patients. Heart rate variability may, therefore, point to better
outcomes for cardiac arrest patients due to it preserving intact autonomic regulation.
Electrocardiographic Changes
In spite of severe prolongation of PR and QT intervals, medically induced hypothermia
shows low potential for proarrhythmic life-threatening arrhythmias. There was no clinically
significant increase in bradycardia or tachycardia. There was a severe shortening of the QRS
interval with subsequent lengthening to QRS interval once hypothermic treatment was ended
(Lebiedz, 2012). Most of hypothermia’s life-threatening arrhythmias occur when temperatures
are below 32̊ C which is below the recommended therapeutic range. There are significant
electrocardiographic changes with induced hypothermia but these changes rarely precipitated
life-threatening arrhythmias.
Coagulation concerns
There have been studies that noted the rate of increased bleeding complications with
hypothermia treatment. Temperatures below 35̊ C have been associated with platelet dysfunction
(Poldermann, 2009). Clinically significant bleeding has been demonstrated with a trend towards
those who had preclinical systemic thrombolysis (Lebiedz, 2012). This may have been cause by
sustained cardiocompression or the use of systemic thrombolysis.
Those who underwent percutaneous coronary intervention (PCI) received anticoagulation
therapy including combined platelet inhibition and heparin. Coagulation concerns after PCI and
hypothermia therapy have mixed results. Observational data supports strict protocols for
hypothermia treatment in order to decrease the risk of bleeding.
Observational data indicates that the risk for severe bleeding is low. This could be due to
patients with bleeding problems not being able to participate in therapeutic hypothermia
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treatment. Those induced hypothermia patients that did have bleeding problems required more
red blood cells overall in order to reach desired hemocrit levels (Poldermann, 2009). With that
being stated, hypothermia patients fared better after bleeding issues. Bleeding issues could lead
to arrhythmias associated with hypotension, but the potential for these issues should be weighed
against the overall benefit of hypothermia treatment.
Hypokalemia
Therapeutic hypothermia can lead to a decrease in serum potassium levels. Proarrhythmic fluxes in potassium have been seen during the initiation and conclusion of
hypothermia treatment (Mirzoyev et al., 2010). During the initiation of therapeutic hypothermia
these fluxes have been shown to precipitate PVT’s and QT prolongation. This suggests that more
rigorous electrolyte testing during induced hypothermia may be required.
When potassium treatment was given, there was no increase in adverse effects. The
degree of QT prolongation, whether from hypothermia or hypokalemia was an indicator of
increased risk of PVT. Once rewarming was initiated, hypokalemia was less likely to lead to
arrhythmias (Mirzoyev et al., 2010). Hypothermia, therefore, seems to beget an arrhythmia
susceptibility phase that could potentially be aggravated. Hence hypokalemia can further subvert
the cardiac rhythm.
Drug Clearance
Hypothermia significantly slows down the body’s metabolic functions. Enzymes have
optimum temperatures in which reactions occur. Hypothermia lowers enzymes reactions
including the clearance of drugs. This is due to the decreased rate of metabolism in the liver
which is highly dependent on enzymes.
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Reductions in metabolism have been noted for many intensive care unit drugs. These
drugs include propofol, epinephrine, norepinephrine, midazolam, barbituates, opiates,
phenytolin, nitrates, and some beta blockers (Poldermann, 2009). Some of these drugs can also
have a decreased effect on a patient in hypothermia as is the case with some vasoactive drugs. It
is also important to keep in mind volume distribution differences and kidney function in the
hypothermic patient.
In general, therapeutic doses should be decreased in order to control toxicity. Another
option would be for drugs with longer half-lives to be used when possible. Because of their
normal slow metabolism a lower body temperature would affect dosing less (Poldermann, 2009).
When increase of dosing is needed it should be done with one time bolus doses instead of
increases in maintenance dose (Poldermann, 2009). The controls of dosing and toxicity rates are
very important when it comes to controlling arrhythmias. Active drugs in the system could have
a synergistic effect when in combination with hypothermia treatment and lead to life threatening
arrhythmias.
Therapeutic induced hypothermia has positive outcomes for those affected by cardiac
arrest. Lee, et al. (2012) has shown a possible correlation between induced hypothermia and a
decrease in myocardial tissue injury. An increased troponin level has been associated with
increased mortality in patients without other signs of myocardial necrosis. Patients treated with
hypothermia showed a decrease in troponin levels.
It is thought that hypothermia treatment has positive effects on cells ability to make
energy. ATP, which is the intracellular energy source for the body, is increased in myocardial
cells of those treated with hypothermia. Injured myocardial cells are thought to have metabolic
failure (Lee, et al. 2012). An increase in ATP in hypothermia treated cells could be due to more
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healthy cells being able to produce energy. This shows injury recovery and ability to make
excess energy in the hypothermia treated patients. With energy excess there is less chance for
arrhythmia producing potential.
The potential for apoptosis of cells was also decreased under therapeutic hypothermia.
The inflammatory response in those who undergo therapeutic hypothermia is decreased.
Therefore, self-limiting cellular behavior is also partly inhibited. Expression of genes that signal
apoptosis was decreased under hypothermic conditions (Lee, et al.2012). Overall this leads to
less cardiac injury and fewer arrhythmias associated with ischemic and damaged myocardial
cells.
The paramount issue related to hypothermia benefits seems to be related to timing. Post
cardiac arrest benefits are related to early cooling. It is then important for healthcare
professionals to recognize those with the potential to benefit from hypothermia treatment.
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Limitations
There are multiple limitations in this integrative literature review. There was a plethora of
available research on induced hypothermia as a treatment for cardiac arrest. However, there were
only a few that dealt with cardiac arrhythmias. Many of the articles available were other
literature reviews which pull from the same data sources. This could be due to the recent
increased interest in hypothermia treatment. Due to the amount of literature reviews the original
interpretation of the primary research could be lost. Therefore, the lack of primary research is a
limitation of this review.
The primary research articles that were available included those with limited sample size
due to specificity of inclusion. It should also be noted that ethnicity was not specified. Therefore,
how these results reflect different ethnicities are not noted. There was no consistency as far as
inclusion to the study. These were all convenience samples, and no information was gathered
about socioeconomic status, education, or co-morbidities. An increase in sample size and
variation is needed.
There was no also no consistency in techniques to determine significant arrhythmias. Due
to the different measures of clinical significance the interpretations could be skewed from one
article to another. There was also no consistency on inclusion criteria. Criteria should be lessened
in order to increase the availability and use of therapeutic hypothermia. The strict criteria could
skew the results of hypothermia treatment.
.
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Recommendations for Nursing
Research
Various research studies about hypothermia and cardiac arrhythmias exist, but there is
still a lack of primary research on the subject. Most research currently comes from other
integrated reviews. More knowledge is needed with an expanded use of hypothermia treatment.
Current research uses the American Heart Association recommendations on hypothermia
treatment candidates. There has been suggestion that hypothermia treatment is in fact underused
and would benefit from expanding its indications. With expanding the indications it would
become more routine and nurses would become more knowledgeable on potential adverse effects
of cardiac arrhythmias. In addition to more primary research and expanded use it may be
beneficial to research the long term effects of those treated with hypothermia treatment.
Research on hospitals adherence to the International Liaison Committee on Resuscitation
would also be beneficial. We now do not know how widespread the adherence is to current
recommendations. In knowing who are actually adhereing we can find higher samples for future
studies, and potentially make revisions to the current guidelines based on experiences at various
hospitals.
Another issue that would be adventatious to look into would be the method of medically
induced hypothermia. Different methods may have better results or could be associated with a
higher level of cardiac arrhythmias. This could be used to further mitigate hypothermia
protocols. It could also help with consistency and quality of care. Determing the easiet and most
effective conditions in which to induce hypothermia could further expand its use. Expanded use
could help with the limited number of participants in the current studies due to hypothermia
suggested protocols limiting qualifying patients.
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Education
Intensive care nurses receive additional training to handle critical therapeutic
hypothermia patients. This group of nurses are the best equiped to handle hypothermia patients.
Healthcare providers need to be cautioned with trying to undertake this treatment in other units
besides the intensive care units. Appropriate staff to patient ratios and the appropriate equipment
must be available for treating cardiac arrest patients with hypothermia treatment.
Nurses need to be educated on what possible complications can arise from hypothermic
treatment. Most important of which is cardiac arrhythmias. Cardiac arrhythmias has the potential
to be caused by numerous interventions post cardiac arrest including hypothermia treatment.
Nurses should be on observing for QT prolongations that has the ability to potentiate dangerous
cardiac arrhythmias. Health care providers should also be taught the importance of monitoring
for electrolyte imbalaces, regular blood tests should be taken. Bleeding should also be monitored
due to the increase possiblity of hemorrage associated with hypothermia treatment.
There should also be education on the recognition of a patient’s suitability for
hypothermia treatment. Many patients are candidates but the hypothermic protocols are not
instituted. Educating health care professionals about the suitability of patients for hypothermia
treatment will offer a better patient outcomes based on current research. There would also be a
larger population to base further research on.
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Figure 1: Consort Diagram
Flow Diagram of Study Selection Process
Key Search Terms = Cardiac Arrest, Induced Hypothermia, Arrhythmias
Limiters = English language, Publication Date of 2003or More Recent

Potentially relevant citations identified after screening of databases
(CINAHL, MEDLINE, PubMed)
(n = 32)

Citations excluded due to not
meeting the inclusion criteria
(n = 9)

Studies retrieved for more detailed review
(n = 23)
Studies excluded after a more detailed
review due to not completely meeting
inclusion criteria
(n =14)

Relevant studies included
which met all of the
inclusion criteria
(n = 9)

Additional studies reviewed and selected
for use (by hand searching credible
reference citations) meeting inclusion
criteria making total n = 12 for review
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Table 1: Table of Evidence
Article

Study Design

Purpose

Participants

Kelly, F. E., & Nolan, J. P. (2010). The effects of mild induced
hypothermia on the myocardium: A systematic review. Anaesthesia,
65(5), 505-515.
a systematic review
“…pathology of cardiac arrest and myocardial infarction, and the
beneficial and harmful effects of mild induced hypothermia.” (p. 505)
58 studies (36 animal studies, 22 human studies)

Results and/or
Key Findings

The effects of induced hypothermia on the myocardium remain unknown
but studies have stuggested a beneficial effect

Nursing
Implications

Patients that are cooled rapidly to achieve target core temperatures for the
recommended period of time may improve neurological outcome.

Article

Study Design

“…studies suggest a beneficial effect of induced hypothermia on the
heart, but further human studies, possibly in the field of cardiology” (p.
513)
Lebiedz, P., Meiners, J., Samol, A., Wasmer, K., Reinecke, H.,
Waltenberger, J., & Eckardt, L. (2012). Electrocardiographic changes
during therapeutic hypothermia. Resuscitation, 83(5), 602-606.
observational single-center study without control group

Purpose

To study electrocardiographic changes and associated events of
therapeutic hypothermia

Participants

“109 comatose survivors of out-of-hospital cardiac arrest.” (602)

Results and/or
Key Findings
Nursing
Implications
Article

Treatment lead to a decreased heart rate, significant prolongation of PR
and QT intervals and cardiac arrhythmias
Induced therapeutic hypothermia can be applied to most patients
following out-of-hospital cardiac arrest without increase in risk of
arrhythmias notwithstanding noteworthy electrocardiographic changes
Storm, C., Hasper, D., Nee, J., Joerres, A., Schefold, J. C., Kaufmann, J.,
& Roser, M. (2011). Severe QTc prolongation under mild hypothermia
treatment and incidence of arrhythmias after cardiac arrest-A prospective
study in 34 survivors with continuous Holter ECG. Resuscitation, 82(7),
28

859-862
Study Design

Purpose

Participants

Results and/or
Key Findings
Nursing
Implications

prospective single center study
“…to evaluate the frequency of malignant arrhythmias and to analyse the
possible effects of hypothermia on QTc interval.” (859)
34 out of hospital cardiac arrest patients
Significant to severe prolongation was found with no increase in
malignant cardiac arrhythmias
Close monitoring of QTc interval and healthcare workers should be
aware of the potentially malignant arrhythmias arising from QTc
prolongation
Anti-arrhythmic drugs and antibiotics should be used with caution due to
possiblity of further QTc prolongation.

Article

Study Design

Purpose

Participants

Results and/or
Key Findings
Nursing
Implications

“…routine and frequent ECG recording with respect to the QTc interval
should become apart of any hypothermia standard operation protocol nd
should be recommended by official guidelines” (p.862)
Mirzoyev, S. A., McLeod, C. J., Bunch, T. J., Bell, M. R., & White, R. D.
(2010). Hypokalemia during the cooling phase of therapeutic
hypothermia and its impact on arrhythmogenesis. Resuscitation, 81(12),
1632-1636.
Retrospective analysis
“…review our experience with the arrhythmogenic milieu during TH and
to propose optimal management strategies.”(1632)
94 sequential out of hospital cardiac arrest patients
Therapeutic hypothermia is associated with significant decline in
potassium during cooling. Hypothermic core temperatures do not protect
against arrhythmias and potassium supplementation is suggested
Induced therapeutic hypothermia during the cooling phase is especially
associated with decreases in serum potassium. Serum potassium should
be monitored to not go below 3.0 to avoid arrhythmias
Decrease in potassium is associated with the propensity for the
develoment of PVT.
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Article

Study Design

Purpose

Participants

Results and/or
Key Findings
Nursing
Implications

Article

Study Design

Purpose

Participants

Results and/or
Key Findings
Nursing
Implications

Tiainen, M., Parikka, H. J., Mäkijärvi, M. A., Takkunen, O. S., Sarna, S.
J., & Roine, R. O. (2009). Arrhythmias and heart rate variability during
and after therapeutic hypothermia for cardiac arrest. Critical Care
Medicine, 37(2), 403-409.
A prospective comparative substudy of a randomize controlled trial of
out of hosptial cardiac arrest patients undergoing therapeutic hypothermia
To evaluate post cardiac arrest hypothermia effects on arrhythmias and
heart rate variability
70 consecutive adults patients resuscitated after out of hospital
ventricular fibrillation
Preserved heart rate variability 24-48 hours may be a predictor of
favorable outcomes for cardiac arrest patients treated with therapeutic
hypothermia
Therapeutic hypothermia was not associated with increased arrhythmias
but there were vast electrocardiographic changes.
Heart rate variability should be monitored due to its association with
positive cardiac outcomes.
Polderman, K. H. (2008). Induced hypothermia and fever control for
prevention and treatment of neurological injuries. The Lancet, 371, 195569
A systematic review
“…to provide information to help guide treatments more effectively with
regard to timing, depth, duration, and effective management of sideeffects.” (1955)
77 patients in whom cooling was initiated very early during
transportation in an ambulance to the hospital after cardiopulmonary
resuscitation, 273 patients witnessed cardiac arrests
Hypothermia has highly promising benefits but remains widely
underused especially in the USA
Hypothermia treatment is drastically underused in the US.
“Studies that establish optimum depth and duration of cooling are also
needed” (p. 1965).
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